New cardiovascular risk guidelines in the U.S. are shifting how doctors classify patient health, moving away from race-based formulas toward more personalized metrics. Research published in JAMA, led by Allison Peng, MD, of the Johns Hopkins University School of Medicine, indicates that 22% of adults will change risk categories under the new PREVENT-atherosclerotic cardiovascular disease … Read more
Tertiary lymphoid structures (TLSs)—organized clusters of immune cells within tumors—are critical for effective cancer immunotherapy, according to a study published in Science. Researchers at the Icahn School of Medicine at Mount Sinai identified type 1 conventional dendritic cells (cDC1s) as the essential architects that form and maintain these structures, suggesting a new path for improving … Read more
Researchers at the Institute of Science Tokyo have identified a molecular mechanism that causes the brain’s recovery window to close following an ischemic stroke. A study published in Nature, led by Jun Tsuyama and Takashi Shichita, reveals that the protein ZFP384 acts as a transcriptional “brake,” suppressing the reparative functions of microglia. By blocking this … Read more
New research led by Niigata University indicates that the risk of Alzheimer’s disease associated with carrying two copies of the APOE4 gene variant is lower in Japanese populations than previously estimated. A meta-analysis published in the journal Molecular Neurodegeneration suggests that Japanese APOE4 homozygotes face a 12–15-fold increased risk of developing the disease, lower than … Read more
Women diagnosed with Parkinson’s disease exhibit a higher amyloid plaque burden in the brain compared to men, according to a study led by the Mayo Clinic Arizona. While men with Parkinson’s are generally at a higher risk of developing dementia, this new research indicates that women harbor more Alzheimer’s-related protein deposits, even when adjusting for … Read more
Combining exercise with GLP-1 receptor agonists like liraglutide significantly improves markers of cardiovascular health in adults with obesity, according to a secondary analysis of a randomized clinical trial conducted at Copenhagen University Hospital Hvidovre. Researchers found that this dual-intervention approach targets subclinical atherogenic burden—measured via carotid intima-media thickness (cIMT)—more effectively than either method alone, providing … Read more
Researchers at the RCSI University of Medicine and Health Sciences have developed a novel mRNA vaccine for neuroblastoma using self-assembling peptide nanoparticles. According to study lead Olga Piskareva, the vaccine, which targets the glypican 2 (GPC2) antigen, reduced tumor volume by 70% in murine models. This approach offers a potential alternative to traditional lipid-based delivery … Read more
Tune Therapeutics has reported early clinical evidence that its epigenetic silencing technology can durably suppress the hepatitis B virus (HBV) in humans by targeting the virus’s “molecular reservoir,” according to data presented at the European Association for the Study of Liver (EASL) Congress. By modulating gene expression without permanently editing DNA, the therapy, TUNE-401, aims … Read more
Unlocking the Genetic Blueprint: The Future of Alzheimer’s Prevention For decades, the search for an Alzheimer’s “cure” has felt like navigating a labyrinth in the dark. While the APOE ε4 gene has long been our primary beacon, a massive, unprecedented genetic study has finally turned on the lights. By analyzing nearly one million individuals, researchers … Read more
The Hidden Link: How Your Heart Talks to Your Brain For decades, medical science treated the heart and the brain as two separate command centers. We knew that a stroke could damage the brain, but the idea that a heart attack—a localized event in the chest—could spark a fire in the neurological system was largely … Read more